ThomasJoseph AllenReidMD

Oncology • Dayton, OH

Cancer Genetics/Cancer Risk Assessment, Genitourinary Oncology, Gynecologic Cancer, Sarcoma

Associate Professor, University of Cincinnati College of Medicine Medical Director Surgical Division Kettering Cancer Center

Join to view full profile

Dr. Reid is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Reid's full profile

Already have an account?

Office
30 E Apple St
Ste 3200
Dayton, OH 45409
Phone+1 937-208-2902

Fax+1 937-208-2014

Education & Training

University of MichiganFellowship, Gynecologic Oncology, 2001 - 2003
Wright State UniversityResidency, Obstetrics and Gynecology, 1997 - 2001
Wright State UniversityInternship, Surgery, 1996 - 1997
Wright State University Boonshoft School of MedicineClass of 1996
The Ohio State UniversityB.S., Biology , 1988 - 1992
Ohio stateB.S., Biology , 1988 - 1988

Certifications & Licensure

OH State Medical License 1997 - 2026
American Board of Obstetrics and Gynecology Obstetrics & Gynecology
American Board of Obstetrics and Gynecology Gynecologic Oncology

Awards, Honors, & Recognition

Fellow (FACS) American College of Surgeons
Fellow (FACOG) American Congress of Obstetricians and Gynecologists

Clinical Trials

Radiation Therapy With or Without Cisplatin in Treating Patients With Recurrent Endometrial Cancer Start of enrollment: 2008 Feb 25
Active, not recruiting
Phase 2
Carboplatin, Paclitaxel and Gemcitabine Hydrochloride With or Without Bevacizumab After Surgery in Treating Patients With Recurrent Ovarian, Epithelial, Primary Peritoneal, or Fallopian Tube Cancer Start of enrollment: 2007 Dec 06
Active, not recruiting
Phase 3
Elesclomol Sodium and Paclitaxel in Treating Patients With Recurrent or Persistent Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cancer Start of enrollment: 2010 Dec 13
Completed
Phase 2
Radiation Therapy With or Without Chemotherapy in Patients With Stage I-IIA Cervical Cancer Who Previously Underwent Surgery Start of enrollment: 2010 Apr 12
Active, not recruiting
Phase 3
Join now to see all

Publications & Presentations

PubMed

Homologous recombination deficiency should be tested for in patients with advanced stage high-grade serous ovarian cancer aged 70 years and over.
Omali Pitiyarachchi, Peter J Ansell, Robert L Coleman, Minh H Dinh, Laura Holman
Gynecologic Oncology. 2024-08-01
Gastric mucosa as a rare recurrence location of endometrial endometrioid adenocarcinoma.
Kathleen Lundeberg, Juliet Wolford, Thomas Reid
Gynecologic Oncology Reports. 2024-06-01
11 citations
Influence of Genomic Landscape on Cancer Immunotherapy for Newly Diagnosed Ovarian Cancer: Biomarker Analyses from the IMagyn050 Randomized Clinical Trial.
Charles N Landen, Luciana Molinero, Habib Hamidi, Jalid Sehouli, Austin Miller
Clinical Cancer Research. 2023-05-01

Professional Memberships

American College of Surgeons - ACS
Member